Skip to main content

Advertisement

SpringerLink
Log in

Craniopharyngioma

  • Published:
Current Treatment Options in Neurology Aims and scope Submit manuscript

Opinion statement

Current management for craniopharyngioma, a low-grade developmental neoplasm of the sellar region, is complicated by the tumor’s proximity to critical neuroanatomical structures, including the optic chiasm and hypothalamus. Recommended preoperative investigations include MRI with and without gadolinium infusion, a neuro-ophthalmologic examination and a complete endocrine evaluation. Strict management of fluids and electrolytes, the judicious use of desmopressin (DDAVP), and the provision of ‘stress’ doses of gluocorticoids will help guide the patient through the perioperative period. Although radical resection has a role as the sole therapeutic modality in some instances, the majority of patients can be appropriately managed by a subtotal resection followed by adjuvant external beam radiotherapy to the involved field using three dimensional treatment planning. The use of external ventricular drains may obviate the requirement for an indwelling cerebrospinal fluid shunt device. Patients with recurrent or progressive disease, in particular those with cystic tumors, may benefit from other therapies, including stereotactic radiosurgery (gamma knife) or intracavitary irradiation. Currently, stereotactic radiotherapy, intracavitary bleomycin, and systemic chemotherapy remain investigational treatment modalities for this challenging disorder.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Surawitz TS, McCarthy BJ, Kupelian V, et al.: Descriptive epidemiology of primary brain and CNS tumors: results from the central brain registry of the United States, 1990–1994. Neurooncol 1999, 1:14–25.

    Google Scholar 

  2. Bunin GR, Surawitz TS, Witman PA, et al.: The descriptive epidemiology of craniopharyngioma. J Neurosurg 1998, 89:547–551.

    PubMed  CAS  Google Scholar 

  3. Sklar CA: Craniopharyngioma: endocrine abnormalities at presentation. Pediatr Neurosurg 1994, 21(suppl 1):18–20. This study outlines the variety of endocrine abnormalities in children presenting with craniopharyngioma. The predominant finding is growth hormone deficiency in 75%. Less than 20% of children have diabetes insipidus preoperatively. This article is found in an issue of Pediatric Neurosurgery devoted entirely to childhood craniopharyngioma.

    PubMed  Google Scholar 

  4. Devile CJ, Grant DB, Hayward RD, Stanhope R: Growth and endocrine sequelae of craniopharyngioma. Arch Dis Child 1996, 75:108–114.

    PubMed  CAS  Google Scholar 

  5. Honegger J, Buchfelder M, Fahlbusch R: Surgical treatment of craniopharyngiomas: endocrinological results. J Neurosurg 1999, 90:251–257. This report documents pre- and postoperative endocrine assessments in 143 patients with craniopharyngioma.

    PubMed  CAS  Google Scholar 

  6. Janzer RC, Burger PC, Giangaspero F, Paulus W:Craniopharyngioma. In WHO Classification of Tumors: Tumors of the Nervous System, Pathology, and Genetics. Edited by Kleihues P, Cavanee WK. Lyon: IARC Press; 2000:244–246.

    Google Scholar 

  7. Harwood-Nash DC: Neuroimaging of childhood craniopharyngioma. Pediatr Neurosurg 1994, 21(suppl 1):2–10.

    PubMed  Google Scholar 

  8. Einhaus SL, Sanford RA: Craniopharyngiomas. In Principles and Practice of Pediatric Neurosurery. Edited by Albright AL, Pollack IF, Adelson PD. New York: Thieme Medical Publishers; 1999:545–561.

    Google Scholar 

  9. Hayward R: The present and future management of childhood craniopharyngioma. Childs Nerv Syst 1999, 15:764–769.

    Article  PubMed  CAS  Google Scholar 

  10. Lehrnbecher T, Muller-Scholden J, Danhauser-Leistner I, et al.: Perioperative fluid and electrolyte management in children undergoing surgery for craniopharyngioma: a 10 year experience in a single institution. Childs Nerv Syst 1998, 14:276–279.

    Article  PubMed  CAS  Google Scholar 

  11. Roth C, Wilken B, Hanefeld F, et al.: Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite. Eur J Endocrinol 1998, 138:89–91. Understanding disorders of leptin regulation may lead to the development of novel treatment strategies for obesity due to hypothalamic dysfunction.

    Article  PubMed  CAS  Google Scholar 

  12. Sklar CA: Craniopharyngioma: endocrine sequelae of treatment. Pediatr Neurosurg 1994, 21(suppl 1):120–123.

    PubMed  Google Scholar 

  13. Riva D, Pantaleoni C, Devoti M, et al.: Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst 1998, 14:179–184.

    Article  PubMed  CAS  Google Scholar 

  14. Anderson CA, Wilkening GN, Filley CM, et al.: Neurobehavioral outcome in pediatric craniopharyngioma. Pediatr Neurosurg 1997, 26:255–260.

    PubMed  CAS  Google Scholar 

  15. Villani RM, Tomei G, Bello L, et al.: Long-term results of treatment for craniopharyngioma in children. Childs Nerv Syst 1997, 13:397–405.

    Article  PubMed  CAS  Google Scholar 

  16. Sutton LN, Wang ZJ, Wehrli SL, et al.: Proton spectroscopy of suprasellar tumors in pediatric patients. Neurosurgery 1997, 41:388–394. Magnetic resonance spectroscopy may be helpful in distinguishing between the following pediatric suprasellar tumors: craniopharyngioma, pituitary adenoma and chiasmatic/hypothalamic astrocytomas.

    Article  PubMed  CAS  Google Scholar 

  17. Moore KD, Couldwell WT: Craniopharyngioma. In Neuro-Oncology: The Essentials. Edited by Bernstein M, Berger M. New York: Thieme Medical Publishers; 2000:409–418.

    Google Scholar 

  18. Tomita T, McLone DG: Radical resections of childhood craniopharyngiomas. Pediatr Neurosurg 1993, 19:6–14.

    Article  PubMed  CAS  Google Scholar 

  19. Weiner HL, Wisoff JH, Kupersmith MJ, et al.: Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery 1994, 35:1001–1010.

    Article  PubMed  CAS  Google Scholar 

  20. Yasargil MG, Curcic M, Kis M, et al.: Total removal of craniopharyngiomas: approaches and long-term results in 144 patients. J Neurosurg 1990, 73:3–11.

    PubMed  CAS  Google Scholar 

  21. Hoffman HJ: Surgical management of craniopharyngioma. Pediatr Neurosurg 1994, 21(suppl 1):44–49.

    PubMed  Google Scholar 

  22. Fahlbusch R, Honegger J, Paulus W, et al.: Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg 1999, 90:237–250.

    PubMed  CAS  Google Scholar 

  23. Laws ER: Transsphenoidal removal of craniopharyngioma. Pediatr Neurosurg 1994, 21(suppl 1):57–63.

    PubMed  Google Scholar 

  24. Rilliet B, de Paul Djientcheu V, Vernet O, et al.: Craniopharyngiomas, results in children and adolescents operated through a transspenoidal approach compared with an intracranial approach. Front Radiat Ther Oncol 1999, 33:114–122.

    PubMed  CAS  Google Scholar 

  25. Habrand J, Ganry O, Couanet D, et al.: The role of radiation therapy in the management of craniopharyngioma: a 25-year experience and review of the literature. Int J Radiat Oncol Biol Phys 1999, 44:255–263.

    Article  PubMed  CAS  Google Scholar 

  26. Wara WM, Sneed PK, Larson DA: The role of radiation therapy in the treatment of craniopharyngioma. Pediatr Neurosurg 1994, 21(suppl 1):98–100.

    PubMed  Google Scholar 

  27. Hetelekidis S, Barnes PD, Tao ML, et al.: 20-year experience in childhood craniopharyngioma. Int J Radiat Oncol Biol Phys 1993, 27:189–195.

    PubMed  CAS  Google Scholar 

  28. Rajan B, Ashley S, Thomas DG, et al.: Craniopharyngioma: improving outcome by early recognition and treatment of acute complications. Int J Radiat Oncol Biol Phys 1997, 37:517–521.

    Article  PubMed  CAS  Google Scholar 

  29. Halperin EC, Constine LS, Tarbell NJ, Kun LE:Pediatric Radiation Oncology, 3rd Edition. Philadelphia: Lippincott, Williams and Wilkins; 1999, 63–79.

    Google Scholar 

  30. Scott RM, Hetelekidis S, Barnes PD, et al.: Surgery, radiation, and combination therapy in the treatment of childhood craniopharyngioma-a 20-year experience. Pediatr Neurosurg 1994, 21(suppl 1):75–81.

    PubMed  Google Scholar 

  31. Fisher, Jenab J, Goldthwaite PT, et al.: Outcomes and failure patterns in childhood craniopharyngiomas. Childs Nerv Syst 1998, 14:558–563.

    Article  PubMed  CAS  Google Scholar 

  32. Brat DJ, James CD, Jedlicka AE, et al.: Molecular genetic alterations in radiation-induced astrocytomas. Am J Pathol 1999, 154:1431–1438.

    PubMed  CAS  Google Scholar 

  33. Suzuki F, Konuma I, Matsumoto M, et al.: Craniopharyngioma with malignant transformation: a report of two cases. Gan No Rinsho 1989, 35:723–728.

    PubMed  CAS  Google Scholar 

  34. Regine WF, Mohiuddin M, Kramer S: Long-term results of pediatric and adult craniopharyngiomas treated with combined surgery and radiation. Radiother Oncol 1993, 27:13–21.

    Article  PubMed  CAS  Google Scholar 

  35. Becker G, Kortmann RD, Skalej M, Bamberg M: The role of radiotherapy in the treatment of craniopharyngioma - indications, results, side effects. Front Radiat Ther Oncol 1999, 33:100–113.

    PubMed  CAS  Google Scholar 

  36. Kobayashi T, Tanaka T, Kida Y: Stereotactic gamma radiosurgery of craniopharyngiomas. Pediatr Neurosurg 1994, 21(suppl 1):69–74.

    PubMed  Google Scholar 

  37. Chung WY, Pan HC, Guo WY, et al.: Protection of visual pathway in gamma knife radiosurgery for craniopharyngiomas. Stereotact Funct Neurosurg 1998, 70(suppl 1):139–151.

    Article  PubMed  Google Scholar 

  38. Tarbell NJ, Barnes P, Scott RM, et al.: Advances in radiation therapy for craniopharyngiomas. Pediatr Neurosurg 1994, 21(suppl 1):101–107.

    PubMed  Google Scholar 

  39. Lunsford LD, Pollack BE, Levine G, et al.: Stereotactic options in the management of craniopharyngioma. Pediatr Neurosurg 1994, 21(suppl 1):90–97.

    PubMed  Google Scholar 

  40. Laws ER, Vance ML: Radiosurgery for pituitary tumors and craniopharyngiomas. Neurosurg Clin N Am 1999, 10:327–336.

    PubMed  Google Scholar 

  41. Plowman PN, Wraith C, Royle N, Grossman AB: Stereotactic radiosurgery. IX. Craniopharyngioma: durable complete imaging responses and indications for treatment. Br J Neurosurg 1999, 13:352–358.

    Article  PubMed  CAS  Google Scholar 

  42. Van Den Berge JH, Blaauw, Breeman WA, et al.: Intracavitary brachytherapy of cystic craniopharyngiomas. J Neurosurg 1992, 77:545–550.

    Article  Google Scholar 

  43. Zeng-min T, Zong-hui L, Gui-quan K, et al.: CT-guided injection of radionuclide for treatment of brain tumors. Stereotact Funct Neurosurg 1992, 59:169–173.

    Article  Google Scholar 

  44. Voges J, Sturm V, Lehrke R, et al.: Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources. Neurosurgery 1997, 40:263–269.

    Article  PubMed  CAS  Google Scholar 

  45. Backlund EO, Aelsson B, Bergstrand CG, et al.: Treatment of craniopharyngiomas: the stereotactic approach in a ten to twenty-three years’ perspective, surgical, radiological and ophthalmological aspects. Acta Neurochir 1989, 99:11–19.

    Article  CAS  Google Scholar 

  46. Shapiro B, Fig LM, Gross MD: Intracavitary therapy of craniopharyngiomas. Q J Nucl Med 1999, 43:367–374.

    PubMed  CAS  Google Scholar 

  47. Blackburn TP, Doughty D, Plowman PN: Stereotactic intracavitary therapy of recurrent cystic craniopharyngioma by instillation of 90yttrium. Br J Neurosurg 1999, 13:359–365.

    Article  PubMed  CAS  Google Scholar 

  48. Barlas O, Bayindir C, Can M: Interstitial irradiation for craniopharyngioma. Acta Neurochir (Wien) 2000, 142:389–395.

    Article  CAS  Google Scholar 

  49. Zanon N: Bleomycin treatment of cystic craniopharyngioma. In Pediatric Neurosurgery. Edited by Choux M, Di Rocco C, Hockley A, Walker M. London: Churchill Livingstone; 1999:541–542.

    Google Scholar 

  50. Cavalheiro S, Sparapani FVC, Franco JOB, et al.: Use of bleomycin in intratumoral chemotherapy for cystic craniopharyngioma. J Neurosurg 1996, 84:124–126.

    Article  PubMed  CAS  Google Scholar 

  51. Savas A, Erdem A, Tun K, Kanpolat Y: Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report. Neurosurgery 2000, 46:213–216.

    Article  PubMed  CAS  Google Scholar 

  52. Bremer AM, Nguyen TQ, Balsys R: Therapeutic benefits of combination chemotherapy with vincristine, BCNU, and procarbazine on recurrent cystic craniopharyngioma: a case report. J Neurooncol 1984, 2:47–51.

    Article  PubMed  CAS  Google Scholar 

  53. Lippens RJ, Rotteveel JJ, Otten BJ, Merx H: Chemotherapy with adriamycin (doxorubicin) and CCNU (lomustine) in four children with recurrent craniopharyngioma. Europ J Paediatr Neurol 1998, 2:263–268.

    Article  CAS  Google Scholar 

  54. Jakacki RI, Cohen BH, Jamison C, et al.: Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas. J Neurosurg 2000, 92:255–260.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Pediatrics and Child Health, Physiology, and Human Anatomy and Cell Science, University of Manitoba, 675 McDermot Avenue, R3E 0V9, Winnipeg, Manitoba, Canada

    David D. Eisenstat MD, MA

Authors
  1. David D. Eisenstat MD, MA
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Eisenstat, D.D. Craniopharyngioma. Curr Treat Options Neurol 3, 77–87 (2001). https://doi.org/10.1007/s11940-001-0026-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11940-001-0026-5

Keywords

Search

Navigation